Cardio Diagnostics Holdings Inc.

**Listen Here:** [Episode Link](https://lnkd.in/gYGRJRE6) Discover the important connection between cardiovascular disease (CVD) and Alzheimer's disease (AD) in this 20-minute episode. Michael Twyman, MD, founder of Apollo Cardiology, dives into the emerging research highlighting how cardiovascular health impacts the risk of developing AD. A noteworthy study in the Journal of the American Heart Association, utilizing data from over 430,000 participants in the UK Biobank, found that individuals who experienced coronary heart disease (CHD) before the age of 45 had a 13% higher risk of developing AD compared to those without CHD. Our CEO, Meesha Dogan, PhD, also shares insights on the vital role of cardiovascular diagnostics and early intervention in preventing chronic diseases. Tune in for a wealth of knowledge and expert perspectives. For more information about Becker's Healthcare, please reach out to Jessica Cole or Scott Becker #podcast #cardiology #healthcare

We are proud to announce our latest expansion to Meijer. Family Medicine Specialists now offers Cardio Diagnostics’ solutions across six locations, including two in a retail healthcare setting. Meesha Dogan, PhD, CEO and Co-Founder of Cardio Diagnostics stated that, “This initiative exemplifies the potential of combining retail convenience with cutting-edge medical diagnostics to deliver personalized healthcare solutions. By making Epi+Gen CHD test now available at another convenient retail location, we are working to ensure individuals can receive timely and accurate assessments of their heart attack risk, empowering them to take proactive steps towards managing their cardiovascular health. This model of accessible, community-based healthcare is a testament to the evolving landscape of preventive medicine and the importance of making advanced medical technologies widely available.” Discover how we're Expanding Access in the Midwest https://lnkd.in/gH3uMRVe

🌟 Discover the Future of Heart Health at the 2024 Onsite Employee Health Clinics Forum with Cardio Diagnostics! 🌟 Cardio Diagnostics will be showcasing our cutting-edge cardiovascular solutions at the 2024 Onsite Employee Health Clinics Forum on June 27th and 28th. Visit our booth to explore how our innovative solutions can seamlessly integrate into onsite clinics, helping more employees get ahead of heart disease. This proactive approach not only creates a more productive workforce but also helps employers reduce costs associated with one of their largest cost centers. #CardioDiagnostics #EmployeeHealth #HealthcareInnovation #HeartHealth #Epigenetics #Genetics

Cardio Diagnostics' CEO, Meesha Dogan, PhD shares her thoughts on the use of AI in transforming healthcare diagnostics in Forbes. AI's Transformative Power In Healthcare Diagnostics "The role of technology in healthcare has undoubtedly grown in the past decade, with artificial intelligence (AI) arguably the most pivotal technology in recent years. AI is already an integral part of today’s healthcare landscape. Virtual health assistants and chatbots can reduce workloads and improve inefficiencies, and advanced diagnostics and clinical decision support tools can improve population health management and patient outcomes—just to name a few examples." https://lnkd.in/gZTCwcb8

Cardio Diagnostics' CEO, Meesha Dogan, PhD shares her thoughts on the use of AI in transforming healthcare diagnostics in Forbes. AI's Transformative Power In Healthcare Diagnostics "The role of technology in healthcare has undoubtedly grown in the past decade, with artificial intelligence (AI) arguably the most pivotal technology in recent years. AI is already an integral part of today’s healthcare landscape. Virtual health assistants and chatbots can reduce workloads and improve inefficiencies, and advanced diagnostics and clinical decision support tools can improve population health management and patient outcomes—just to name a few examples." https://lnkd.in/gZTCwcb8

I am beyond excited to announce our new strategic partnership with Navierre, an innovative digital health and care navigation platform that allows patients to take control of their health and consolidate so many sources of disparate healthcare data. Some companies discuss patient-centricity, while others build patient-centric companies from the ground up. Navierre is one such company, and we couldn't be more proud to partner with Mustafa Dinani and his team. More to come, but you can read the announcement here: https://lnkd.in/gxUuHsfr

Attending #ACC24 this weekend? Join Cardio Diagnostics Holdings Inc. after day 1 of the American College of Cardiology Conference ends on Saturday for an evening reception titled "Precision Diagnostics: The Future of Cardiovascular Disease Prevention, Detection & Management," hosted at the Signia Hilton, just a heartbeat away from the conference.   As we delve deeper into the conference's revelations, this event promises to: - Unveil the next frontier in cardiac health through Cardio Diagnostics’ precision diagnostics. - Foster discussions on innovative strategies for tackling heart disease.   📍 Location: Signia Hilton (located next to the ACC Conference) 📅 Date: This Saturday, 5-7PM 🌟 For Whom?: Heart disease-conscious individuals, healthcare innovators, clinicians, cardiologists, and anyone ready to be part of the conversation on advancing cardiovascular care.   RSVP Today! Limited RSVP’s available. Secure your spot and don't miss this opportunity to engage with thought leaders and explore how Cardio Diagnostics is using precision diagnostics to revolutionize how we provide care for cardiovascular disease. https://lnkd.in/gv4jSTiF

For #NationalPublicHealthWeek, Cardio Diagnostics is dedicated to addressing the significant challenges in cardiac care through:   - Innovation in Care: Introducing cutting-edge diagnostics that transform cardiac healthcare practices by leveraging AI and epigenetics. - Early Detection: Utilizing these innovative tools to enable early identification of cardiovascular risks, setting the stage for life-saving interventions. - Precision Medicine: Bringing precision to cardiac care by tailoring diagnostics, prevention and treatment to a patient's biology, ensuring personalized care. - Proactive Approach: This approach shifts the paradigm from reactive treatment to proactive management of heart health, focusing on prevention and early intervention. - Empowering Healthcare Professionals: Providing medical professionals with the tools and insights needed for more effective and efficient patient care. Cardio Diagnostics Holdings Inc. aims to transform cardiac care and improve public health outcomes by addressing these key areas. Together, we can revolutionize the approach to cardiovascular health and make a lasting impact on the well-being of individuals and communities. #publichealth #heartdisease

While it’s mostly behind the scenes, on this #NationalPhysiciansWeek, I’m appreciative of the important role our medical directors and collaborating physicians play in supporting our MinuteClinic and virtual care practice within Retail Health. Their support, mentorship and expertise strengthen our provider care team. I’d also like to highlight our board-certified Virtual Primary Care physicians, who work every day to help increase access to high-quality and preventive care. Grateful this week and every week for their dedication and partnership!   As our Health Care Delivery business continues to evolve, I look forward to partnering with our network of physicians to improve health outcomes and deliver connected patient care in communities across the country, including working with the dedicated primary care providers at Oak Street Health who are helping older adults stay healthy and live life more fully.

We are excited to present our latest innovations at the Becker's Healthcare 14th Annual Meeting, hosted in our lovely city of #Chicago. Our commitment is deeply rooted in the advancement of biotechnology, with a particular focus on the revolutionary potential of epigenetics and machine learning. These cutting-edge tools are key to our mission to transform the diagnosis of cardiovascular diseases. The conference offers an exceptional platform for us to showcase our pioneering work in merging epigenetic biomarkers with artificial intelligence analytics. Cardio Diagnostics Holdings Inc.'s solutions improve access to new state-of-the-art tools for CHD risk assessments, detection, and managing heart disease, providing clinicians with the first epigenetic-based tools to address heart disease from primary to secondary prevention. #BeckersAnnualMeeting